@article{7b67abfbe60d483fb6cb4e0ef59f08cf,
title = "Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease",
abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To examine the efficacy and safety of insulin and other pharmacological interventions for lowering glucose-lowering levels in patients with diabetes and CKD.",
author = "Clement Lo and Tadashi Toyama and Yoichiro Hirakawa and Min Jun and Alan Cass and Carmel Hawley and Helen Pilmore and Badve, {Sunil V.} and Vlado Perkovic and Sophia Zoungas",
note = "Funding Information: • Alan Cass: The Menzies School of Health Research has received unconditional research funding from AMGEN, Merck and Novartis for research in chronic kidney disease in Indigenous populations. Funding Information: • Vlado Perkovic: has received support from Boehringer Ingelheim for Advisory Boards, and his employer has received payments from Boehringer Ingelheim and Merck for Advisory activities, and has a contract for the conduct of a clinical study of glucose lowering with Janssen Publisher Copyright: {\textcopyright} 2015 The Cochrane Collaboration.",
year = "2015",
month = aug,
day = "5",
doi = "10.1002/14651858.CD011798",
language = "English",
volume = "2015",
journal = "Cochrane Database of Systematic Reviews",
issn = "1361-6137",
publisher = "John Wiley and Sons Ltd",
number = "8",
}
